Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report) shares fell 7% during mid-day trading on Monday . The company traded as low as GBX 1.80 ($0.02) and last traded at GBX 1.85 ($0.02). 391,878 shares were traded during mid-day trading, a decline of 69% from the average session volume of 1,262,751 shares. The stock had previously closed at GBX 1.99 ($0.03).
Cizzle Biotechnology Stock Performance
The business has a 50 day moving average price of GBX 1.98 and a two-hundred day moving average price of GBX 1.82. The company has a market cap of £7.09 million, a P/E ratio of -178.90 and a beta of 0.38.
About Cizzle Biotechnology
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021.
Featured Articles
- Five stocks we like better than Cizzle Biotechnology
- ETF Screener: Uses and Step-by-Step Guide
- Rocket Lab is the Right Stock for the Right Time
- What Does a Stock Split Mean?
- SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
- Buy P&G Now, Before It Sets A New All-Time High
- Celsius Holdings: Big Drop, Big Opportunity? Analysts Say Yes
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
